hydroxychloroquine has been researched along with Cough in 20 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Cough: A sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation. It is a protective response that serves to clear the trachea, bronchi, and/or lungs of irritants and secretions, or to prevent aspiration of foreign materials into the lungs.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Recurrences of COVID-19 were observed in a patient with long-term usage of hydroxychloroquine, leflunomide, and glucocorticoids due to her 30-year history of rheumatoid arthritis (RA)." | 5.05 | A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab. ( Cai, S; Dong, L; Li, M; Sun, W, 2020) |
| "Since the emergence of coronavirus disease 2019 (COVID-19), neurological symptoms, syndromes, and complications associated with this multi-organ viral infection have been reported and the various aspects of neurological involvement are increasingly uncovered." | 2.72 | Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature. ( Aghavali, S; Babadi, M; Daraie, P; Emamikhah, M; Jalili, M; Mehrabani, M; Mohaghegh, F; Pouranian, M; Rohani, M; Zaribafian, M, 2021) |
| "Moreover, PTSD in patients with COVID-19 is not associated with the increased risk of CFS." | 1.62 | Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19. ( Aalipour, MA; Darazam, IA; Ghorbani, F; Pakdaman, H; Ramezani, M; Sagharichi, M; Simani, L, 2021) |
| "Key words: Coronavirus disease 2019 (COVID-19), Meningoencephalitis, Pneumonia." | 1.56 | A Case of 45-Year Man Who Succumbed to Coronavirus Disease 2019 (COVID-19). ( Khan, MA, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (10.00) | 24.3611 |
| 2020's | 18 (90.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gutta, S | 1 |
| Das, S | 1 |
| Kodiatte, TA | 1 |
| Vimala, LR | 1 |
| Bartiromo, M | 1 |
| Borchi, B | 1 |
| Botta, A | 1 |
| Bagalà, A | 1 |
| Lugli, G | 1 |
| Tilli, M | 1 |
| Cavallo, A | 1 |
| Xhaferi, B | 1 |
| Cutruzzulà, R | 1 |
| Vaglio, A | 1 |
| Bresci, S | 1 |
| Larti, A | 1 |
| Bartoloni, A | 1 |
| Cirami, C | 1 |
| Aminian, A | 1 |
| Kermansaravi, M | 1 |
| Azizi, S | 1 |
| Alibeigi, P | 1 |
| Safamanesh, S | 1 |
| Mousavimaleki, A | 1 |
| Rezaei, MT | 1 |
| Faridi, M | 1 |
| Mokhber, S | 1 |
| Pazouki, A | 1 |
| Safari, S | 1 |
| Bozzalla Cassione, E | 1 |
| Zanframundo, G | 1 |
| Biglia, A | 1 |
| Codullo, V | 1 |
| Montecucco, C | 1 |
| Cavagna, L | 1 |
| Gemcioglu, E | 1 |
| Davutoglu, M | 1 |
| Ozdemir, EE | 1 |
| Erden, A | 1 |
| Medetalibeyoğlu, A | 1 |
| Şenkal, N | 1 |
| Çapar, G | 1 |
| Köse, M | 1 |
| Tükek, T | 1 |
| Cai, S | 1 |
| Sun, W | 1 |
| Li, M | 1 |
| Dong, L | 1 |
| Mattioli, M | 1 |
| Fustini, E | 1 |
| Gennarini, S | 1 |
| Firouzabadi, FD | 1 |
| Firouzabadi, MD | 1 |
| Ghalehbaghi, B | 1 |
| Jahandideh, H | 1 |
| Roomiani, M | 1 |
| Goudarzi, S | 1 |
| Khan, MA | 2 |
| Khan, S | 1 |
| Ahmad, Z | 1 |
| Khan, F | 1 |
| Asif, H | 1 |
| Zia-Ur-Rahman, A | 1 |
| Gurkan, O | 1 |
| Yilmaz, A | 1 |
| Cengel, F | 1 |
| Altunok, ES | 1 |
| Ekin, EE | 1 |
| Choi, NH | 1 |
| Silver, ES | 1 |
| Fremed, M | 1 |
| Liberman, L | 1 |
| Miao, H | 1 |
| Li, H | 1 |
| Yao, Y | 1 |
| Wu, M | 1 |
| Lu, C | 1 |
| Wang, J | 1 |
| Tian, M | 1 |
| Li, Y | 1 |
| Luo, P | 1 |
| Gu, J | 1 |
| Yuan, B | 1 |
| Wang, S | 1 |
| Zhao, X | 1 |
| Gan, W | 1 |
| Zhao, D | 1 |
| Matangila, JR | 1 |
| Nyembu, RK | 1 |
| Telo, GM | 1 |
| Ngoy, CD | 1 |
| Sakobo, TM | 1 |
| Massolo, JM | 1 |
| Muyembe, BM | 1 |
| Mvwala, RK | 1 |
| Ilunga, CK | 1 |
| Limbole, EB | 1 |
| Ntalaja, JM | 1 |
| Kongo, RM | 1 |
| Mondal, R | 1 |
| Ganguly, U | 1 |
| Deb, S | 1 |
| Shome, G | 1 |
| Pramanik, S | 1 |
| Bandyopadhyay, D | 1 |
| Lahiri, D | 1 |
| Ortiz Molina, E | 1 |
| Hernandez Pailos, R | 1 |
| Pola Guillen, M | 1 |
| Pascual Pedreno, A | 1 |
| Rodriguez Rodriguez, E | 1 |
| Hernandez Martinez, A | 1 |
| Emamikhah, M | 1 |
| Babadi, M | 1 |
| Mehrabani, M | 1 |
| Jalili, M | 1 |
| Pouranian, M | 1 |
| Daraie, P | 1 |
| Mohaghegh, F | 1 |
| Aghavali, S | 1 |
| Zaribafian, M | 1 |
| Rohani, M | 1 |
| Simani, L | 1 |
| Ramezani, M | 1 |
| Darazam, IA | 1 |
| Sagharichi, M | 1 |
| Aalipour, MA | 1 |
| Ghorbani, F | 1 |
| Pakdaman, H | 1 |
| Lee, E | 1 |
| Seo, JH | 1 |
| Kim, HY | 1 |
| Yu, J | 1 |
| Jhang, WK | 1 |
| Park, SJ | 1 |
| Kwon, JW | 1 |
| Kim, BJ | 1 |
| Do, KH | 1 |
| Cho, YA | 1 |
| Kim, SA | 1 |
| Jang, SJ | 1 |
| Hong, SJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Incidence of COVID-19 Test Conversion in Post-surgical Patients[NCT04392323] | 111 participants (Actual) | Interventional | 2020-05-13 | Completed | |||
| Efficacy and Security of the Magnesium and Vitamin D Combination as Adjuvant Treatment of Post-COVID Syndrome. A Randomised Double-blind Clinical Trial[NCT05630339] | 150 participants (Actual) | Interventional | 2022-01-30 | Completed | |||
| Neuropsychological Sequelae as a Risk Factor for Long COVID-19 Fatigue[NCT05323318] | 200 participants (Anticipated) | Observational | 2022-04-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for hydroxychloroquine and Cough
| Article | Year |
|---|---|
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Antirheumatic Agents; Antiviral Agents; Arthritis, R | 2020 |
Update on recommendations for the diagnosis and treatment of SARS-CoV-2 infection in children.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Asymptomatic Diseases; Betacoronavirus; Biomarke | 2020 |
Meningoencephalitis associated with COVID-19: a systematic review.
Topics: Adult; Aged; Antiviral Agents; Azithromycin; Confusion; Cough; COVID-19; COVID-19 Drug Treatment; Dy | 2021 |
Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature.
Topics: Adult; Anticonvulsants; Ataxia; Azithromycin; Clonazepam; Cough; COVID-19; COVID-19 Drug Treatment; | 2021 |
16 other studies available for hydroxychloroquine and Cough
| Article | Year |
|---|---|
Organising pneumonia in Rhupus syndrome.
Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis; Cough; Diagnosis, Differential; Drug Ther | 2019 |
Threatening drug-drug interaction in a kidney transplant patient with coronavirus disease 2019 (COVID-19).
Topics: Adult; Antiviral Agents; Betacoronavirus; C-Reactive Protein; Ciliopathies; Cobicistat; Common Cold; | 2020 |
Bariatric Surgical Practice During the Initial Phase of COVID-19 Outbreak.
Topics: Adult; Anti-Retroviral Agents; Betacoronavirus; Coronavirus Infections; Cough; COVID-19; Dyspnea; Fa | 2020 |
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Azathioprine; Betacoronavirus; Clinical Labora | 2020 |
Are type 1 interferons treatment in Multiple Sclerosis as a potential therapy against COVID-19?
Topics: Adult; Anti-Bacterial Agents; Antimalarials; Azithromycin; Betacoronavirus; Coronavirus Infections; | 2020 |
Characteristics of the initial patients hospitalized for COVID-19: a single-center report
Topics: Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhi | 2020 |
Heart transplant recipient patient with COVID-19 treated with tocilizumab.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Anticoagulants; Cardiomyopathy, Dilated; C | 2020 |
Have the symptoms of patients with COVID-19 changed over time during hospitalization?
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Coronavirus Infections; Cough; COVID-19; Diar | 2020 |
A Case of 45-Year Man Who Succumbed to Coronavirus Disease 2019 (COVID-19).
Topics: Anti-Bacterial Agents; Anticoagulants; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus; | 2020 |
Diarrhoea: An Atypical Presentation of COVID-19.
Topics: Azithromycin; Betacoronavirus; Coronavirus; Coronavirus Infections; Cough; COVID-19; Diarrhea; Femal | 2020 |
COVID-19 Pulmonary Infection with Pneumothorax in a Young Patient.
Topics: Anti-Bacterial Agents; Anticoagulants; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus; | 2020 |
COVID-19 reveals Brugada pattern in an adolescent patient.
Topics: Antiviral Agents; Brugada Syndrome; C-Reactive Protein; Chest Pain; Consanguinity; Cough; COVID-19; | 2020 |
Clinical characteristics of COVID-19 patients hospitalized at Clinique Ngaliema, a public hospital in Kinshasa, in the Democratic Republic of Congo: A retrospective cohort study.
Topics: Adult; Aged; Blood Coagulation; Chloroquine; Coinfection; Comorbidity; Cough; COVID-19; COVID-19 Dru | 2020 |
COVID-19 infection in symptomatic pregnant women at the midpoint of the pandemic in Spain: a retrospective analysis.
Topics: Adult; Anosmia; Anti-Bacterial Agents; Anticoagulants; Antiviral Agents; C-Reactive Protein; Cesarea | 2020 |
Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19.
Topics: Adult; Aged; Antiviral Agents; Cough; COVID-19; COVID-19 Drug Treatment; Dementia; Drug Combinations | 2021 |
Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19.
Topics: Adult; Aged; Antiviral Agents; Cough; COVID-19; COVID-19 Drug Treatment; Dementia; Drug Combinations | 2021 |
Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19.
Topics: Adult; Aged; Antiviral Agents; Cough; COVID-19; COVID-19 Drug Treatment; Dementia; Drug Combinations | 2021 |
Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19.
Topics: Adult; Aged; Antiviral Agents; Cough; COVID-19; COVID-19 Drug Treatment; Dementia; Drug Combinations | 2021 |
Toxic inhalational injury-associated interstitial lung disease in children.
Topics: APACHE; Bronchi; Child, Preschool; Cough; Cyclophosphamide; Disinfectants; Dyspnea; Enzyme Inhibitor | 2013 |